Get all your news in one place.
100's of premium titles.
One app.
Start reading
France 24
France 24
Health
FRANCE 24

WHO says risk of global Ebola spread is low, but high at national, regional levels

People offload a shipment of more than 15 tons of supplies donated by UNICEF as part of the response to the Ebola virus outbreak at Bunia National Airport in Bunia, Congo, May 19, 2026.
Staff offload a shipment of UNICEF medical supplies at Bunia National Airport in Bunia, Congo on May 19, 2026. © Moses Sawasawa, AP

The head of the World Health Organization (WHO) on Wednesday said the Ebola epidemic risk was high at the national and regional levels and low at the global level.

The head of the World Health Organization said on Wednesday the risk of global spread of the Ebola outbreak in DR Congo and Uganda is high at national, regional levels but low at the global level.

WHO Director-General Tedros Adhanom Ghebreyesus said so far 51 cases have been confirmed in Congo in the northern provinces of Ituri and North Kivu provinces in Congo, “although we know the scale of the epidemic is much larger".

He said Uganda has also told the UN health agency of two confirmed cases in Uganda’s capital, Kampala. “Beyond the confirmed cases, there are almost 600 suspected cases and 139 suspected,” he said. “We expect those numbers to keep increasing.”

Read moreWHO declares global health emergency over Ebola outbreak in Congo and Uganda

A WHO ​Emergency Committee met ‌on Tuesday in Geneva and confirmed that the latest Ebola outbreak ‌of the rare Bundibugyo strain of ​the virus is a public health emergency of international concern but not ​a pandemic emergency, he ​said.

Tedros declared the emergency at the ​weekend, the first time a WHO chief has taken that step without first consulting experts, ⁠due to the urgency of the ⁠situation, ​he said.

© France 24

No approved vaccines for rare strain

The WHO on Tuesday expressed concern over the “scale and speed” of the Bundibugyo outbreak in eastern Congo.

The virus spread undetected for weeks after the first known death as authorities tested for a more common type of Ebola and came up negative, health experts and aid workers said. The Bundibugyo virus has no approved medicines or vaccines.

Congo was expecting shipments from the USand Britain of an experimental vaccine for different types of Ebola, developed by researchers at Oxford, said Jean-Jacques Muyembe, a virus expert at the National Institute of Biomedical Research.

“We will administer the vaccine and see who develops the disease,” he said. But experts said such efforts would take time.

Ebola is a highly contagious virus and can be contracted via bodily fluids such as vomit, blood or semen. The disease it causes is rare but severe and often fatal. Symptoms include fever, headache, muscle pain, weakness, diarrhea, vomiting, stomach pain and unexplained bleeding or bruising.

During an outbreak more than a decade ago that killed more than 11,000 people, many were infected while washing bodies for funerals.

(FRANCE 24 with AFP, AP and Reuters)

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.